NEW YORK, Nov. 1, 2012 /PRNewswire/ -- Bernstein Liebhard LLP is investigating whether the Board of Directors of Schiff Nutrition International, Inc. ("Schiff" or the "Company") (NYSE: SHF) breached its fiduciary duty to its shareholders in agreeing to sell Schiff to Bayer HealthCare LLC.
Under the terms of the agreement, Schiff shareholders will receive $34 in cash for each share they own. The investigation is focused on the potential unfairness of the price to Schiff shareholders and the process by which the Schiff Board of Directors considered and approved the transaction.
If you are interested in discussing your rights as a Schiff stockholder, with no obligation or cost to you, please contact
U. Seth Ottensoser at:
(877) 779-1414or Ottensoser@bernlieb.com.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts